Navigation Links
Tourtellotte Solutions Blazes Trail with New Release of Clinical Trial Supply Chain Simulator

tcVisualize(TM) 3.0 with Monte Carlo brings predictability to whole range

of Phase II, III and IV Clinical Trials

WAYLAND, Mass., Sept. 4 /PRNewswire/ -- Tourtellotte Solutions, a global leader in off-the-shelf and custom supply chain software for the biopharmaceutical, retail, and consumer goods industries, today announced the release of its tcVisualize(TM) 3.0 clinical trial supply simulator. The latest generation tcVisualize software now offers wide support for variable dosing, cross-protocol drug pooling, Monte Carlo simulations, and adaptive trial designs. Among many other enhancements, the 3.0 release also expands modeling up the supply chain to include pharmaceutical ingredients and other kit components.

The Monte Carlo capabilities of tcVisualize 3.0, developed with close involvement of some of the world's premiere bio-statisticians, increase the accuracy of modeling significantly - and are key to the support of adaptive trials. Monte Carlo statistical techniques allow the application to simulate a multiplicity of scenarios, weigh the possibilities, and deliver answers with high - and specific - degrees of confidence.

"I'm proud that our team was able to pack so many significant advances into a single release of tcVisualize," said Ed Tourtellotte, CEO of Tourtellotte Solutions. "We're giving clients broader functionality - and far greater power - than they can get anywhere else."

One of the most significant of tcVisualize 3.0's new features is its support of variable dosing (variable titration) trials, which are in increasing use by many biopharmaceuticals. tcVisualize 3.0 is the only tool that can model and compare scenarios around the intricacies of unpredictable dosing, allowing users to avoid the usual supply crises and excess overage.

Also new is tcVisualize 3.0's support of drug pooling, an emerging supply technique that reduces waste and minimizes risk by allowing supply and safety stock to be shared among protocols. tcVisualize 3.0 can be configured to simulate multiple studies simultaneously so that stock can be shared at specified depots and even sites.

One of tcVisualize 3.0's many smaller enhancements is its new ability to model the usage of active pharmaceutical ingredients (or any other constituent element) in dispensing units, and to report consumption at both the dispensing unit and constituent level. This is the first step in a direction that is of great interest to the industry: a clinical manufacturing demand plan at the enterprise level, driven by reliable study models. Tourtellotte Solutions will be pursuing this aggressively in future releases of tcVisualize.

For more information about Tourtellotte Solutions and the tcVisualize(TM) 3.0 product, please call David Diamond at 1.866.653.2770 x103, or visit

About Tourtellotte Solutions

Tourtellotte Solutions is a global leader in off-the-shelf and custom supply-chain software for the pharmaceutical, retail, and consumer goods markets. Tourtellotte Solutions' tcVisualize(TM), a groundbreaking clinical supply chain modeling and forecasting application for the pharmaceutical industry, is used by several of the largest pharmaceuticals. Tourtellotte also sells RockBlocks(R), which is widely used for managing sourcing in the retail, consumer goods, branded apparel, and footwear industries. Tourtellotte Solutions is a privately-held company headquartered in Wayland, Massachusetts.

Contacts: Karen Adelman

KBA Folio Communications


SOURCE Tourtellotte Solutions
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
2. Ties Between Physicians and Drug Companies Still Too Strong: the Prescription Project Offers Solutions to Prevent Conflicts of Interest
3. Human Genome Sciences Reports Growing Evidence That Its TRAIL Receptor Antibodies Have Significant Potential in the Treatment of a Broad Range of Cancers
4. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
5. Mayo Clinic News Release: Mayo Clinic-led Study Improves Breast Cancer Risk Prediction in Women with Atypia
6. Lupus Foundation of America Statement on Results for Clinical Study of CellCept Released by Aspreva Pharmaceutical Company
7. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
8. Phase IIIb Clinical Data Validate the Overall and Cardiovascular Safety Profile of Cycloset (A Quick Release Formulation of Bromocriptine Mesylate) in Patients with Type 2 Diabetes
9. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
10. VeroScience Late-Breaking Abstract on Cycloset (A Quick Release Formulation of Bromocriptine Mesylate) Accepted for Poster Presentation at American Diabetes Association 67th Scientific Sessions
11. Critical Therapeutics Announces the Publication of Data for ZyfloCR (Zileuton) Extended-Release Tablets in the Journal of Asthma
Post Your Comments:
(Date:6/24/2016)... Mass. , June 24, 2016   ... Spaulding Rehabilitation Network,s Dean Center for Tick ... Physical Medicine and Rehabilitation, MIT Hacking Medicine, University ... for Innovation, today announced the five finalists of ... for Lyme disease.  More than 100 scientists, clinicians, ...
(Date:6/24/2016)... Research and Markets has ... 2015-2025: Applications, Technologies, Forecasts" report to their ... Electronics, Smart Skin, Structural Health Monitoring, Composite Smart ... electronics involves electronic and/or electrical components and circuits ... structures such as vehicle bodies or conformally placed ...
(Date:6/24/2016)... 2016 Dehaier Medical Systems Ltd. (NASDAQ: ... markets and sells medical devices and wearable sleep respiratory ... strategic cooperation agreement with Hongyuan Supply Chain Management Co., ... June 20, 2016, to develop Dehaier,s new Internet medical ... Dehaier will leverage Hongyuan Supply Chain,s sales platform to ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, the ... affiliation with Tennessee Counseling Association. This new relationship allows TherapySites to ... Counseling Association, adding exclusive benefits and promotional offers. , "TCA is extremely excited ...
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A Forever Recovery, ... Festival and World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility ... home to some of the world’s leading providers of cereal and other breakfast foods. ...
(Date:6/25/2016)... D.C. (PRWEB) , ... June 25, 2016 , ... ... discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, ... their work on several important health care topics including advance care planning, healthcare ...
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
Breaking Medicine News(10 mins):